Skip to Content

Notice

Importer of Controlled Substances Registration

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

ACTION:

Notice of registration.

SUMMARY:

Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.

End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices.

CompanyFR docketPublished
Chattem Chemicals, Inc81 FR 62177September 8, 2016.
Anderson Brecon, Inc81 FR 71766October 18, 2016.
Hospira82 FR 11241February 21, 2017.
Myoderm82 FR 13134March 9, 2017.
Meridian Medical Technologies82 FR 13135March 9, 2017.
Start Printed Page 25336
Meda Pharmaceuticals, Inc82 FR 13137March 9, 2017.
Wildlife Laboratories, Inc82 FR 14914March 23, 2017.
Xcelience82 FR 16420April 4, 2017.

The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.

Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed companies.

Start Signature

Dated: May 23, 2017.

Louis J. Milione,

Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2017-11388 Filed 5-31-17; 8:45 am]

BILLING CODE 4410-09-P